Credit Suisse’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $943K | Hold |
155,646
| – | – | ﹤0.01% | 2300 |
|
|
2023
Q4 | $945K | Buy |
+155,646
| New | +$945K | ﹤0.01% | 2357 |
|
|
2023
Q2 | – | Sell |
-61,879
| Closed | -$86K | – | 3153 |
|
|
2023
Q1 | $86K | Buy |
61,879
+25
| +0% | +$35 | ﹤0.01% | 3200 |
|
|
2022
Q4 | $123K | Sell |
61,854
-245
| -0.4% | -$488 | ﹤0.01% | 3279 |
|
|
2022
Q3 | $124K | Buy |
62,099
+591
| +1% | +$1.18K | ﹤0.01% | 3374 |
|
|
2022
Q2 | $196K | Buy |
61,508
+555
| +0.9% | +$1.77K | ﹤0.01% | 3322 |
|
|
2022
Q1 | $255K | Buy |
60,953
+4,722
| +8% | +$19.8K | ﹤0.01% | 3271 |
|
|
2021
Q4 | $270K | Sell |
56,231
-2,313
| -4% | -$11.1K | ﹤0.01% | 3340 |
|
|
2021
Q3 | $313K | Buy |
58,544
+4,282
| +8% | +$22.9K | ﹤0.01% | 3239 |
|
|
2021
Q2 | $280K | Sell |
54,262
-9,679
| -15% | -$49.9K | ﹤0.01% | 3304 |
|
|
2021
Q1 | $430K | Sell |
63,941
-45,325
| -41% | -$305K | ﹤0.01% | 3028 |
|
|
2020
Q4 | $499K | Buy |
109,266
+43,993
| +67% | +$201K | ﹤0.01% | 2981 |
|
|
2020
Q3 | $253K | Sell |
65,273
-17,300
| -21% | -$67.1K | ﹤0.01% | 2999 |
|
|
2020
Q2 | $393K | Sell |
82,573
-186,032
| -69% | -$885K | ﹤0.01% | 2824 |
|
|
2020
Q1 | $935K | Buy |
268,605
+177,180
| +194% | +$617K | ﹤0.01% | 2153 |
|
|
2019
Q4 | $441K | Buy |
91,425
+31,675
| +53% | +$153K | ﹤0.01% | 2989 |
|
|
2019
Q3 | $174K | Sell |
59,750
-38,328
| -39% | -$112K | ﹤0.01% | 3220 |
|
|
2019
Q2 | $703K | Sell |
98,078
-34,382
| -26% | -$246K | ﹤0.01% | 2579 |
|
|
2019
Q1 | $1.88M | Buy |
132,460
+70,144
| +113% | +$994K | ﹤0.01% | 1937 |
|
|
2018
Q4 | $844K | Buy |
62,316
+9,089
| +17% | +$123K | ﹤0.01% | 2415 |
|
|
2018
Q3 | $1.18M | Sell |
53,227
-491,023
| -90% | -$10.9M | ﹤0.01% | 2299 |
|
|
2018
Q2 | $8.93M | Buy |
+544,250
| New | +$8.93M | 0.01% | 1074 |
|